ATE253573T1 - Heterocyclycarboxamid-derivate und ihre verwendung als therapeutische mittel - Google Patents
Heterocyclycarboxamid-derivate und ihre verwendung als therapeutische mittelInfo
- Publication number
- ATE253573T1 ATE253573T1 AT96924847T AT96924847T ATE253573T1 AT E253573 T1 ATE253573 T1 AT E253573T1 AT 96924847 T AT96924847 T AT 96924847T AT 96924847 T AT96924847 T AT 96924847T AT E253573 T1 ATE253573 T1 AT E253573T1
- Authority
- AT
- Austria
- Prior art keywords
- disorders
- pct
- date jan
- methylene
- sec
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9514380.6A GB9514380D0 (en) | 1995-07-13 | 1995-07-13 | Therapeutic agents |
| PCT/EP1996/002890 WO1997003071A1 (en) | 1995-07-13 | 1996-07-02 | Heterocyclylcarboxamide derivatives and their use as therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE253573T1 true ATE253573T1 (de) | 2003-11-15 |
Family
ID=10777626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96924847T ATE253573T1 (de) | 1995-07-13 | 1996-07-02 | Heterocyclycarboxamid-derivate und ihre verwendung als therapeutische mittel |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US5935973A (de) |
| EP (1) | EP0839145B1 (de) |
| JP (1) | JPH11508599A (de) |
| KR (1) | KR19990028918A (de) |
| CN (1) | CN1071755C (de) |
| AT (1) | ATE253573T1 (de) |
| AU (1) | AU708890B2 (de) |
| BG (1) | BG62771B1 (de) |
| BR (1) | BR9609506A (de) |
| CA (1) | CA2223472A1 (de) |
| CZ (1) | CZ388497A3 (de) |
| DE (1) | DE69630604T2 (de) |
| GB (1) | GB9514380D0 (de) |
| HR (1) | HRP960348A2 (de) |
| HU (1) | HUP9901485A3 (de) |
| IL (1) | IL122540A (de) |
| MX (1) | MX9800084A (de) |
| NO (1) | NO980129D0 (de) |
| NZ (1) | NZ313164A (de) |
| PL (1) | PL324529A1 (de) |
| RU (1) | RU2169147C2 (de) |
| SK (1) | SK2498A3 (de) |
| TR (1) | TR199800041T1 (de) |
| TW (1) | TW454006B (de) |
| WO (1) | WO1997003071A1 (de) |
| ZA (1) | ZA965921B (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9811879D0 (en) * | 1998-06-03 | 1998-07-29 | Knoll Ag | Therapeutic agents |
| GB9915616D0 (en) * | 1999-07-05 | 1999-09-01 | Knoll Ag | Therapeutic agents |
| UA73981C2 (en) * | 2000-03-10 | 2005-10-17 | Merck Patent Gmbh | (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit |
| US6608058B2 (en) | 2000-04-17 | 2003-08-19 | Dong Wha Pharm. Ind. Co., Ltd. | 6-methylnicotinamide derivatives as antiviral agents |
| WO2002039988A2 (en) * | 2000-11-14 | 2002-05-23 | Merck Patent Gmbh | Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists |
| GB0112836D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
| US8106074B2 (en) | 2001-07-13 | 2012-01-31 | Pierre Fabre Medicament | Pyridin-2-yl-methylamine derivatives for treating opiate dependence |
| HUP0402092A3 (en) | 2001-07-26 | 2010-06-28 | Merck Patent Gmbh | Use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts for preparation of pharmaceutical compositions |
| JP4681548B2 (ja) | 2003-07-22 | 2011-05-11 | アステックス・セラピューティクス・リミテッド | ３，４−ジ置換１ｈ−ピラゾール化合物および、そのサイクリン依存性キナーゼ（ｃｄｋ）およびグリコーゲン・シンセターゼ・キナーゼ−３（ｇｓｋ−３）調節剤としての使用 |
| CN1980929A (zh) * | 2004-02-24 | 2007-06-13 | 比奥阿克松医疗技术股份有限公司 | 4－取代哌啶衍生物 |
| JP4604583B2 (ja) * | 2004-07-20 | 2011-01-05 | ダイソー株式会社 | １−アミド−３−（２−ヒドロキシフェノキシ）−２−プロパノール誘導体、ならびに２−アミドメチル−１，４−ベンゾジオキサン誘導体の製造法 |
| US20080161251A1 (en) | 2005-01-21 | 2008-07-03 | Astex Therapeutics Limited | Pharmaceutical Compounds |
| MX2007008781A (es) | 2005-01-21 | 2007-09-11 | Astex Therapeutics Ltd | Compuestos farmaceuticos. |
| TWI457122B (zh) | 2007-07-20 | 2014-10-21 | Orion Corp | 作為用於治療周邊和中央神經系統疾病之alpha2C拮抗劑的2,3－二氫苯並[1,4]戴奧辛－2－基甲基衍生物 |
| MX2010011724A (es) * | 2008-04-29 | 2010-11-30 | Nsab Af Neurosearch Sweden Ab | Moduladores de neurotransmision de dopamina. |
| PE20150228A1 (es) * | 2012-06-11 | 2015-02-19 | Bristol Myers Squibb Co | Profarmacos de acido fosforamidico de 5-[5-fenil-4-(piridin-2-ilmetilamino)quinazolin-2-il]piridin-3-sulfonamida |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8302622D0 (en) * | 1983-01-31 | 1983-03-02 | Celltech Ltd | Immunoassay |
| EP0200960A1 (de) * | 1985-05-08 | 1986-11-12 | Abbott Laboratories | Fluoreszenzpolarisationsimmunoassay auf Gesamtöstriol |
| AU639536B2 (en) * | 1990-03-15 | 1993-07-29 | Pharmacia & Upjohn Company | Therapeutically useful heterocyclic indole compounds |
| US5240943A (en) * | 1991-12-19 | 1993-08-31 | G. D. Searle & Co. | Benzopyran class iii antiarrhythmic agents |
| GB9314758D0 (en) * | 1993-07-16 | 1993-08-25 | Wyeth John & Brother Ltd | Heterocyclic derivatives |
| GB9318431D0 (en) * | 1993-09-06 | 1993-10-20 | Boots Co Plc | Therapeutic agents |
| FR2724383B1 (fr) * | 1994-09-13 | 1996-10-18 | Synthelabo | Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique |
-
1995
- 1995-07-13 GB GBGB9514380.6A patent/GB9514380D0/en active Pending
-
1996
- 1996-07-02 RU RU98102441/04A patent/RU2169147C2/ru active
- 1996-07-02 TR TR1998/00041T patent/TR199800041T1/xx unknown
- 1996-07-02 WO PCT/EP1996/002890 patent/WO1997003071A1/en not_active Application Discontinuation
- 1996-07-02 AT AT96924847T patent/ATE253573T1/de not_active IP Right Cessation
- 1996-07-02 CZ CZ973884A patent/CZ388497A3/cs unknown
- 1996-07-02 AU AU65172/96A patent/AU708890B2/en not_active Ceased
- 1996-07-02 JP JP9505471A patent/JPH11508599A/ja not_active Withdrawn
- 1996-07-02 CN CN96195477A patent/CN1071755C/zh not_active Expired - Fee Related
- 1996-07-02 EP EP96924847A patent/EP0839145B1/de not_active Expired - Lifetime
- 1996-07-02 MX MX9800084A patent/MX9800084A/es not_active Application Discontinuation
- 1996-07-02 HU HU9901485A patent/HUP9901485A3/hu unknown
- 1996-07-02 CA CA002223472A patent/CA2223472A1/en not_active Abandoned
- 1996-07-02 DE DE69630604T patent/DE69630604T2/de not_active Expired - Fee Related
- 1996-07-02 NZ NZ313164A patent/NZ313164A/xx unknown
- 1996-07-02 IL IL12254096A patent/IL122540A/en not_active IP Right Cessation
- 1996-07-02 US US08/981,671 patent/US5935973A/en not_active Expired - Lifetime
- 1996-07-02 PL PL96324529A patent/PL324529A1/xx unknown
- 1996-07-02 BR BR9609506A patent/BR9609506A/pt unknown
- 1996-07-02 SK SK24-98A patent/SK2498A3/sk unknown
- 1996-07-02 KR KR1019980700220A patent/KR19990028918A/ko not_active Application Discontinuation
- 1996-07-12 ZA ZA9605921A patent/ZA965921B/xx unknown
- 1996-07-12 HR HR9514380.6A patent/HRP960348A2/hr not_active Application Discontinuation
- 1996-12-19 TW TW085115692A patent/TW454006B/zh not_active IP Right Cessation
-
1997
- 1997-12-23 BG BG102145A patent/BG62771B1/bg unknown
-
1998
- 1998-01-12 NO NO980129A patent/NO980129D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TR199800041T1 (xx) | 1998-05-21 |
| HUP9901485A3 (en) | 2001-03-28 |
| IL122540A0 (en) | 1998-06-15 |
| CA2223472A1 (en) | 1997-01-30 |
| DE69630604D1 (de) | 2003-12-11 |
| AU708890B2 (en) | 1999-08-12 |
| AU6517296A (en) | 1997-02-10 |
| RU2169147C2 (ru) | 2001-06-20 |
| HUP9901485A2 (en) | 2000-07-28 |
| NO980129L (no) | 1998-01-12 |
| BG102145A (en) | 1998-11-30 |
| EP0839145B1 (de) | 2003-11-05 |
| SK2498A3 (en) | 1998-09-09 |
| PL324529A1 (en) | 1998-06-08 |
| JPH11508599A (ja) | 1999-07-27 |
| DE69630604T2 (de) | 2004-09-23 |
| CZ388497A3 (cs) | 1998-06-17 |
| MX9800084A (es) | 1998-03-29 |
| NZ313164A (en) | 1999-07-29 |
| BR9609506A (pt) | 1999-06-01 |
| WO1997003071A1 (en) | 1997-01-30 |
| IL122540A (en) | 2001-10-31 |
| US5935973A (en) | 1999-08-10 |
| GB9514380D0 (en) | 1995-09-13 |
| HRP960348A2 (en) | 1998-04-30 |
| NO980129D0 (no) | 1998-01-12 |
| KR19990028918A (ko) | 1999-04-15 |
| CN1190967A (zh) | 1998-08-19 |
| CN1071755C (zh) | 2001-09-26 |
| BG62771B1 (bg) | 2000-07-31 |
| EP0839145A1 (de) | 1998-05-06 |
| TW454006B (en) | 2001-09-11 |
| ZA965921B (en) | 1998-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69423767D1 (de) | 1,4-Benzodioxan-Derivate mit Affinität für D2 Rezeptoren und Nützlichkeit in der Behandlung von Psychosen | |
| ATE253573T1 (de) | Heterocyclycarboxamid-derivate und ihre verwendung als therapeutische mittel | |
| NO20042141L (no) | Terapeutiske quinolonforbindelser med 5-HT-antagonistiske egenskaper | |
| MXPA04004073A (es) | Compuestos de quinolina terapeuticos con propiedades antagonistas 5-ht. | |
| NO940163L (no) | Tricyklisk kondenserte heterocykliske forbindelser, deres fremstilling og anvendelse | |
| ATE178886T1 (de) | 1-aryl-2-acylamino-ethan-verbindungen und ihre verwendung als neurokinin- insbesondere als neurokinin-1-antagonisten | |
| NO993172L (no) | Sulfonamid-forbindelser med 5-HT-reseptor-aktivitet | |
| DE60213576D1 (de) | ANTIDEPRESSIVE AZAHETEROCYCLYLMETHYL-DERIVATE VON 2,3-DIHYDRO-1,4-DIOXINOi2,3-föCHINOXALIN | |
| DE60201592D1 (de) | ANTIDEPRESSIVE INDOLTETRAHYDROPYRIDIN-DERIVATE VON 2,3-DIHYDRO-7H[1,4]DIOXINO[2,3-e]INDOL | |
| TR199701756T1 (xx) | 5-HT e�ilimli resept�re sahip yo�unla�t�r�lm�� tiazol t�revleri. | |
| WO2001072741A3 (en) | N-benzodioxanylmethyl-1-piperidyl-methylamine compounds for the treatment of central nervous system disorders | |
| ATE167671T1 (de) | Beta-aminovinylketone, verfahren zur herstellung und ihre verwendung bei der herstellung von beta- diketonen | |
| BR9910927A (pt) | Composto, composições farmacêuticas, processo para tratamento de depressão, ansiedade, psicoses, doença de parkinson, obesidade, hipertensão, sìndrome de tourette, disfunção sexual, toxicomania, abuso de droga, distúrbios cognitivos, doença de alzheimer, demência senil, comportamento obsessivo-compulsivo, ataques de pânico, indisposições alimentares, anorexia, distúrbios cardiovascular e cerebrovascular, enxaqueca, diabetes melitus não dependente de insulina, hiperglicemia, constipação, arritmia, distúrbios do sistema neuroendócrino, tensão, hipertrofia prostática, sintomas extrapiramidais induzidos por drogas ou espasticidade, uso de um composto, e, processo para preparação do composto | |
| AR005368A1 (es) | Compuestos de heteroarilcarboxamidas, las composiciones farmaceuticas que los contienen, la aplicacion de dichos compuestos para la preparacion demedicamentos, un metodo para tratar enfermedades con dichos compuestos y los procedimientos para preparar dichos compuestos. | |
| TH65445A (th) | สารประกอบเฮเทอโรไซคลิคที่สามารถใช้รักษาโรค |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |